20 mg lyophilised (freeze-dried) · blend - BPC-157 (10 mg) + TB-500 (10 mg)
$155.00 CAD
Wolverine is a 20 mg recovery-focused research blend containing BPC-157 (10 mg) and TB-500 (10 mg), two widely studied tissue-repair peptides.
For laboratory and research use only - not for human consumption.
Checking the live COA archive for the newest lot documentation.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsWolverine is a recovery-focused research blend containing BPC-157 (10 mg) and TB-500 (10 mg) in a 20 mg lyophilised vial. It is supplied for laboratory and research use only.
Research interest is in combined soft-tissue recovery, connective-tissue models, angiogenesis signalling, and tissue-remodelling pathways associated with BPC-157 and TB-500.
BPC-157 is studied for effects on angiogenic and repair signalling, while TB-500 is studied as a thymosin beta-4 fragment associated with actin regulation and cell-migration pathways. Wolverine combines both in a single research blend.
Wolverine is supplied strictly as a research compound blend - not for human consumption. BPC-157 and TB-500 are not approved medicines in this context and are offered only for qualified laboratory research.
A single vial containing 20 mg lyophilised (freeze-dried) blend: BPC-157 (10 mg) + TB-500 (10 mg). Lyophilized powder: store in freezer (−20 °C).
Selected literature for BPC-157 and thymosin beta-4/TB-500 informs research context for this blend.
